Aptevo Therapeutics Inc. (APVO) Investor Relations Documents

Aptevo Therapeutics Inc. (APVO) investor relations documents from the company's IR site: 1 presentation, 15 press releases; latest deck 2026-06-22. Read in-app with summaries. First-party data.

22 June 2026 Investor Presentation: Aptevo is a clinical-stage immuno-oncology company developing multispecific antibodies, with mipletamig showing clinical proof-of-concept in AML.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-14Press releaseAptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
2026-08-13Press releaseAptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
2026-08-12Press releaseAptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
2026-07-27Press releaseAptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone
2026-06-30Press releaseAptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targ
2026-06-22Presentation22 June 2026 Investor Presentation
2026-05-28Press releaseAptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
2026-05-27Press releaseAptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Eq
2026-05-13Press releaseAptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
2026-05-06Press releaseAptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substanti
2026-03-26Press releaseAptevo Provides State of the Business Report and 2025 Financial Results
2026-03-19Press releaseRead More
2026-03-10Press releaseRead More
2026-02-03Press releaseRead More
2026-01-09Press releaseRead More
Press releaseRead More

APVO overview · APVO earnings · APVO financials · APVO KPIs · APVO ownership · APVO peers · APVO filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.